about
Lectin of Concanavalin A as an anti-hepatoma therapeutic agentMultiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesisIdentification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotionGlycoproteins and glycoproteomics in pancreatic cancerThe Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaRas inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosisGalectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myelomaProteomic profiling identifies breast tumor metastasis-associated factors in an isogenic modelGalectins and gliomas.Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.Galectin-1 and its involvement in hepatocellular carcinoma aggressivenessGalectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coli.Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.Galectin-1 is up-regulated by RASSF1A gene in human gastric carcinoma cell line SGC7901.Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulvenThe secretome of alginate-encapsulated limbal epithelial stem cells modulates corneal epithelial cell proliferation.Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosisPancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.Disaccharide binding to galectin-1: free energy calculations and molecular recognition mechanism.Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.Protein profiling of human nonpigmented ciliary epithelium cell secretome: the differentiation factors characterization for retinal ganglion cell lineGalectin-1-mediated biochemical controls of melanoma and glioma aggressive behaviorSize does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity.The Cytotoxicity of Elderberry Ribosome-Inactivating Proteins Is Not Solely Determined by Their Protein Translation Inhibition ActivityStructural features for α-galactomannan binding to galectin-1.The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy.Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer.Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Carbohydrate-conjugated fluorescent silica nanoprobes for selective detection of galectin-1 and prostate cancer cells.Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein sheddingGalectin-1 as a potential therapeutic target in autoimmune disorders and cancer.Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosisDeregulation of annexin-A1 and galectin-1 expression in precancerous gastric lesions: intestinal metaplasia and gastric ulcerSuppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy.Galectin-1 and immunotherapy for brain cancer.Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development.
P2860
Q21284430-E2B8CB31-F84F-4BA2-B167-6E4CF4B43F74Q24302420-10088064-7195-45AD-8C6A-E07A2E014B32Q27332209-1A815266-CD68-46F4-A9C3-15EC9FAC4AB2Q28071108-40FC9F32-2742-460B-9ADD-74D1AEE716D7Q28075523-C0612EF5-4612-41CD-A271-629CF645B253Q28081459-5109E426-F3D3-4191-BF74-27AB7842AA19Q28287799-ABFF7ADC-0BCD-45AC-B568-E7B70E47E8CCQ28742668-79FE079E-069E-43B3-B716-1F0FECDE2BC1Q33268322-7909B7E6-3C95-497E-BDBD-44A89634D87CQ33588438-1459CC68-579E-430C-A698-D5E88869AB34Q33625197-97E091F9-47CE-4376-82BB-2AC0BD4B4BD2Q33692511-D20C6EB5-4EC1-496D-95B5-940C4DF8B76FQ33811652-9D724072-ABDD-47FC-8358-EAD998EBDB96Q33844721-88C8E2F7-53BB-40F1-B0B0-FA161434D9A3Q34310815-9CD73E68-6E68-44D8-B988-748B59B8B096Q34589227-3D722EE9-49D3-42A9-970D-B1154AF882B3Q34876896-E37BFFF3-1943-4391-87F9-82CAB64779B9Q35085674-1904E47A-5EB3-4F6F-8E82-363A9C013953Q35111396-7F59C476-698C-4D77-A2EC-8FC7CDFCB182Q35144698-409481EE-2CCE-4C90-AB2A-C6CFF937DF6EQ35161285-D231180A-70B4-47D4-ADDD-1F427159E053Q35167495-13D76C3B-0555-4BA4-B468-F4CCBC4B55D2Q35228388-D5A39ECA-3AC3-4613-BC87-D1D939D57D28Q35376137-A0844C2A-826C-4D87-9DAC-2353E0A098ECQ35684312-52708F32-5C80-4C5C-AE5A-1F8AF3B9F314Q35779469-1B844E31-D1BD-4F3E-A94B-E49ACC697525Q35920312-3E828942-6A76-4533-8531-9B57A875F214Q36379734-3CDAA72B-D4A9-4A71-9432-7C09434C4D53Q36616418-52F4CAB1-8E4F-4493-8C8F-0D14DF1C4F35Q36642433-86EF6AAD-2E50-481D-86F3-85073E0E2215Q36672445-251E8215-0885-487F-A58B-2AB3A573E8F8Q36786004-71872CB9-2B8B-458C-8C32-489D2E20EC32Q36804675-AF4BDEFE-F286-4FC4-8A2B-DB953A60C40EQ37032635-F570DBE6-E9C0-4910-9846-7A78E76B93C5Q37375269-E081B4BB-5ED6-46E0-BBED-592B78C52C19Q37513855-A06BC9F9-AF7B-4F2B-9D23-8CEFE7C2C1A9Q37639722-6F805976-8CCA-448B-AFB4-E170C21DE57AQ37744139-E1D7D41E-8D5D-4421-A1E0-E807FDB7F083Q37862237-CAC3DB0E-1EFE-4103-AAEE-1AB6E32FAB18Q37867110-A4942C44-F888-4AF3-ADA6-EF66FD7EBCB9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Galectin-1 as a potential cancer target.
@ast
Galectin-1 as a potential cancer target.
@en
type
label
Galectin-1 as a potential cancer target.
@ast
Galectin-1 as a potential cancer target.
@en
prefLabel
Galectin-1 as a potential cancer target.
@ast
Galectin-1 as a potential cancer target.
@en
P2860
P921
P356
P1476
Galectin-1 as a potential cancer target.
@en
P2093
G A Rabinovich
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602493
P407
P577
2005-04-01T00:00:00Z
2005-04-11T00:00:00Z
P5875
P6179
1040097320